The Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy documents suggest that antibiotics usage should be based on clinical signs of infection, blood CRP level, and blood procalcitonin level. This evidence concerns the gene CRP and chronic obstructive pulmonary disease.